FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elliott Antman

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sameer T Amin; Eugene Braunwald; Charles Contant; David A Morrow; Sabina Murphy; Sarah Sloan; Elliott M Antman
Dynamic TIMI risk score for STEMI.
Paul K Whelton; Cheryl A M Anderson; Elliott M Antman; Lawrence J Appel; Norman Campbell; Sandra B Dunbar; Edward D Frohlich; John E Hall; Mariell Jessup; Darwin R Labarthe; Graham A MacGregor; Ralph L Sacco; Frank M Sacks; Jeremiah Stamler; Dorothea K Vafiadis; Linda V Van Horn
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations.
Sergio Leonardi; Renato D Lopes; Elliott M Antman; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Megan L Neely; L Kristin Newby; Laine Thomas; Pierluigi Tricoci; Harvey D White; Kenneth W Mahaffey
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elliott Antman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sameer T Amin; Eugene Braunwald; Charles Contant; David A Morrow; Sabina Murphy; Sarah Sloan; Elliott M Antman
Dynamic TIMI risk score for STEMI.
Journal of the American Heart Association 2013;2(1):e003269.
2012: Paul K Whelton; Cheryl A M Anderson; Elliott M Antman; Lawrence J Appel; Norman Campbell; Sandra B Dunbar; Edward D Frohlich; John E Hall; Mariell Jessup; Darwin R Labarthe; Graham A MacGregor; Ralph L Sacco; Frank M Sacks; Jeremiah Stamler; Dorothea K Vafiadis; Linda V Van Horn
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations.
Circulation 2012;126(24):2880-9.
2012: Sergio Leonardi; Renato D Lopes; Elliott M Antman; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Megan L Neely; L Kristin Newby; Laine Thomas; Pierluigi Tricoci; Harvey D White; Kenneth W Mahaffey
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
Journal of the American College of Cardiology 2012;60(22):2296-304.
2012: Gordon Guyatt; Andy Oxman; Milo Puhan; Holger J Schünemann; Kevin Wilson; Timothy Wilt; Mark Woodhead; Elie A Akl; Elliott M Antman; David Gutterman
Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Proceedings of the American Thoracic Society 2012;9(5):256-61.
2012: Owen Mogabgab; Satishkumar Mohanavelu; Marc S Sabatine; Stephen D Wiviott; Elliott M Antman; Christopher P Cannon; Robert P Giugliano; Eugene Braunwald
Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarction.
Chronobiology international 2012;29(10):1390-6.
2012: Elliott M Antman; Robert A Harrington
Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being.
JAMA : the journal of the American Medical Association 2012;308(17):1743-4.
2012: Elliott M Antman; Robert Harrington; Gordon F Tomaselli
Usefulness of medical conferences.
JAMA : the journal of the American Medical Association 2012;308(1):31-2; author reply 32-3.
2012: James G Jollis; Peter H Moyer; Franklin D Pratt; Mayme Lou Roettig; Ivan C Rokos; Anna R Acuña; Elliott M Antman; Peter B Berger; Christopher B Granger; Timothy D Henry; Alice K Jacobs
Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline.
Circulation. Cardiovascular quality and outcomes 2012;5(4):423-8.
2012: Michael P Thomas; Elliott M Antman; Robert M Califf; Karen Chiswell; Marc Cohen; James J Ferguson; Shaun G Goodman; Michael C Kontos; Kenneth W Mahaffey; Richard C Becker
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin.
Journal of thrombosis and thrombolysis 2012;34(1):114-9.
2012: Elliott M Antman
Implications of contemporary clinical trials series: the Placement of Aortic Transcatheter Valve trial (PARTNER).
Circulation 2012;125(25):3054.
2012: Christian T Ruff; Fredrik Schersten; Ricardo Seabro-Gomes; Stephen D Wiviott; Elliott M Antman; Luciano Baracioli; Eugene Braunwald; Robert P Giugliano; Herbertus Heuer; Chaim Lotan; Bela Merkely; Sabina A Murphy
Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world.
International journal of cardiology 2012;155(3):424-9.
2012: Marc P Bonaca; Eugene Braunwald; Sabina A Murphy; Christian T Ruff; Stephen D Wiviott; Elliott M Antman; David A Morrow
American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38).
Circulation 2012;125(4):577-83.
2011: Niteesh K Choudhry; Joaquim Fernandes; Robert J Glynn; Joy L Lee; Raisa Levin; Lonny Reisman; Sebastian Schneeweiss; William H Shrank; Claire Spettell; Michele Toscano; Elliott M Antman; Jerry Avorn; Troyen Brennan
Full coverage for preventive medications after myocardial infarction.
The New England journal of medicine 2011;365(22):2088-97.
2011: Stephen D Wiviott; Elliott M Antman; Nihar Desai; Sabina A Murphy; Giuseppe Musumeci; Michael Ragosta; Eugene Braunwald
Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies.
The American journal of cardiology 2011;108(7):905-11.
2011: Robin Mathews; Eric D Peterson; Matthew T Roe; Jorge F Saucedo; Elliott M Antman; Seth W Glickman; Alice K Jacobs; Shuang Li; Stephen D Wiviott; Tracy Y Wang
Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines.
Circulation 2011;124(2):154-63.
2011: Willibald Hochholzer; Gilles Montalescot; Stephen D Wiviott; Elliott M Antman; Charles F Contant; Anthony J Dalby; Robert P Giugliano; Jianping Guo; Eugene Braunwald
Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38).
Circulation 2011;123(23):2681-9.
2011: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation 2011;123(18):e426-579.
2011: Kenneth W Mahaffey; Karen S Pieper; Yuliya Lokhnygina; Robert M Califf; Elliott M Antman; Neal S Kleiman; Shaun G Goodman; Harvey D White; Sunil V Rao; Judith S Hochman; Marc Cohen; Jacques J Col; Matthew T Roe; James J Ferguson
The impact of postrandomization crossover of therapy in acute coronary syndromes care.
Circulation. Cardiovascular quality and outcomes 2011;4(2):211-9.
2011: Elliott M Antman
Evidence and education.
Circulation 2011;123(6):681-5.
2010: Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James M Scheiman; Laurence S Sperling; Gordon F Tomaselli
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Circulation 2010;122(24):2619-33.
2010: Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James M Scheiman; Laurence S Sperling; Gordon F Tomaselli
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Journal of the American College of Cardiology 2010;56(24):2051-66.
2010: Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James M Scheiman; Laurence S Sperling; Gordon F Tomaselli
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
The American journal of gastroenterology 2010;105(12):2533-49.
2010: Jessica L Mega; Tabassome Simon; Jean-Philippe Collet; Jeffrey L Anderson; Elliott M Antman; Kevin Bliden; Christopher P Cannon; Nicolas Danchin; Betti Giusti; Paul A Gurbel; Benjamin D Horne; Jean-Sebastian Hulot; Adnan Kastrati; Gilles Montalescot; Franz-Josef Neumann; Lei Shen; Dirk Sibbing; P Gabriel Steg; Dietmar Trenk; Stephen D Wiviott; Marc S Sabatine
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.
JAMA : the journal of the American Medical Association 2010;304(16):1821-30.
2010: Jessica L Mega; Sandra L Close; Stephen D Wiviott; Lei Shen; Joseph R Walker; Tabassome Simon; Elliott M Antman; Eugene Braunwald; Marc S Sabatine
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
Lancet 2010;376(9749):1312-9.
2010: Christian T Ruff; Robert P Giugliano; Elliott M Antman; Sharon E Crugnale; Tomas Bocanegra; Michele Mercuri; James Hanyok; Indravadan Patel; Minggao Shi; Dan Salazar; Carolyn H McCabe; Eugene Braunwald
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
American heart journal 2010;160(4):635-41.
2010: Robert P Giugliano; Roberto R Giraldez; David A Morrow; Elliott M Antman; C Michael Gibson; Satishkumar Mohanavelu; Sabina A Murphy; Carolyn H McCabe; Eugene Braunwald
Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
European heart journal 2010;31(17):2103-10.
2010: David A Morrow; Elliott M Antman; Keith A A Fox; Harvey D White; Robert P Giugliano; Sabina A Murphy; Carolyn H McCabe; Eugene Braunwald
One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial.
European heart journal 2010;31(17):2097-102.
2010: Yuri B Pride; Patricia Tung; Satishkumar Mohanavelu; Cafer Zorkun; Stephen D Wiviott; Elliott M Antman; Robert P Giugliano; Eugene Braunwald; C Michael Gibson
Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy.
JACC. Cardiovascular interventions 2010;3(8):806-11.
2010: Stephen D Wiviott; Elliott M Antman; Eugene Braunwald
Prasugrel.
Circulation 2010;122(4):394-403.
2010: Stephen D Wiviott; Elliott M Antman; Eugene Braunwald
Mortality in the TRITON trial: update from the FDA prasugrel action package.
The American journal of cardiology 2010;106(2):293-4.
2010: Marc Cohen; Glenn N Levine; Karen S Pieper; Lan Lan; Elliott M Antman; Philip E Aylward; Harvey D White; Neal S Kleiman; Robert M Califf; Kenneth W Mahaffey
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;75(6):928-35.
2010: Kenneth W Mahaffey; Simon T Tonev; Sarah A Spinler; Glenn N Levine; Richard Gallo; John Ducas; Shaun G Goodman; Elliott M Antman; Richard C Becker; Anatoly Langer; Harvey D White; Philip E Aylward; Jacques J Col; James J Ferguson; Robert M Califf
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
International journal of cardiology 2010;139(2):123-33.
2010: Raymond J Gibbons; Elliott M Antman; Sidney C Smith
Has guideline development gone astray? No.
BMJ (Clinical research ed.) 2010;340():c343.
2010: James R Harkness; Marc S Sabatine; Eugene Braunwald; David A Morrow; Sarah Sloan; Stephen D Wiviott; Robert P Giugliano; Elliott M Antman; Christopher P Cannon; Benjamin M Scirica
Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.
American heart journal 2010;159(1):55-62.
2009: Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; eric peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Journal of the American College of Cardiology 2009;54(23):2205-41.
2009: Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Alice K Jacobs; Judith S Hochman; Harlan Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; eric peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(7):E25-68.
2009: Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; eric peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation 2009;120(22):2271-306.
2009: Jason P Linefsky; Min Lin; Karen S Pieper; Craig J Reist; Lisa G Berdan; Elliott M Antman; Shaun G Goodman; John K French; Sema Guneri; Matthew T Roe; L Kristin Newby; Robert A Harrington; James J Ferguson; Robert M Califf; Kenneth W Mahaffey
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
The American journal of cardiology 2009;104(10):1330-5.
2009: Michelle L O'Donoghue; Eugene Braunwald; Elliott M Antman; Sabina A Murphy; Eric R Bates; Yoseph Rozenman; Alan D Michelson; Raymond W Hautvast; Peter N Ver Lee; Sandra L Close; Lei Shen; Jessica L Mega; Marc S Sabatine; Stephen D Wiviott
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.
Lancet 2009;374(9694):989-97.
2009: Marc S Sabatine; Elliott M Antman; Petr Widimsky; Iftikhar O Ebrahim; Robert G Kiss; André Saaiman; Rostislav Polasek; Charles F Contant; Carolyn H McCabe; Eugene Braunwald
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.
Lancet 2009;374(9692):787-95.
2009: Yuri B Pride; Stephen D Wiviott; Jacqueline Buros; Cafer Zorkun; M Umer Tariq; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
American heart journal 2009;158(3):e21-6.
2009: Michelle O'Donoghue; Elliott M Antman; Eugene Braunwald; Sabina A Murphy; Philippe Gabriel STEG; Ariel Finkelstein; William F Penny; Viliam Fridrich; Carolyn H McCabe; Marc S Sabatine; Stephen D Wiviott
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
Journal of the American College of Cardiology 2009;54(8):678-85.
2009: Rebecca E Wrishko; C Steven Ernest; David S Small; Ying G Li; Govinda J Weerakkody; Jeffrey R Riesmeyer; William L Macias; Shashank Rohatagi; Daniel Salazar; Elliott M Antman; Stephen D Wiviott; Eugene Braunwald; Lan Ni
Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38.
Journal of clinical pharmacology 2009;49(8):984-98.
2009: Roberto R Giraldez; Stephen D Wiviott; José Carlos Nicolau; Satishkumar Mohanavelu; David A Morrow; Elliott M Antman; Robert P Giugliano
Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis.
Drugs 2009;69(11):1433-43.
2009: Elliott M Antman; Raymond J Gibbons
Clinical practice guidelines and scientific evidence.
JAMA : the journal of the American Medical Association 2009;302(2):143-4; author reply 145-7.
2009: Alan D Michelson; Andrew L Frelinger; Eugene Braunwald; William E Downey; Dominick J Angiolillo; Nicholas P Xenopoulos; Joseph A Jakubowski; Youfu Li; Sabina A Murphy; Jie Qin; Carolyn H McCabe; Elliott M Antman; Stephen D Wiviott
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.
European heart journal 2009;30(14):1753-63.
2009: David A Morrow; Stephen D Wiviott; Harvey D White; Jose C Nicolau; Ezio Bramucci; Sabina A Murphy; Marc P Bonaca; Christian T Ruff; Benjamin M Scirica; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Circulation 2009;119(21):2758-64.
2009: Jessica L Mega; Sandra L Close; Stephen D Wiviott; Lei Shen; Richard D Hockett; John T Brandt; Joseph R Walker; Elliott M Antman; William L Macias; Eugene Braunwald; Marc S Sabatine
Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.
Circulation 2009;119(19):2553-60.
2009: Elliott M Antman; eric peterson
Tools for guiding clinical practice from the american heart association and the american college of cardiology: what are they and how should clinicians use them?
Circulation 2009;119(9):1180-5.
2009: Susan Cheng; David A Morrow; Sarah Sloan; Elliott M Antman; Marc S Sabatine
Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
Circulation 2009;119(9):1195-202.
2009: Roberto R Giraldez; Marc S Sabatine; David A Morrow; Satishkumar Mohanavelu; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.
American heart journal 2009;157(3):517-24.
2009: Gilles Montalescot; Stephen D Wiviott; Eugene Braunwald; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Elliott M Antman
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.
Lancet 2009;373(9665):723-31.
2009: Jessica L Mega; Sandra L Close; Stephen D Wiviott; Lei Shen; Richard D Hockett; John T Brandt; Joseph R Walker; Elliott M Antman; William Macias; Eugene Braunwald; Marc S Sabatine
Cytochrome p-450 polymorphisms and response to clopidogrel.
The New England journal of medicine 2009;360(4):354-62.
2009: C Michael Gibson; Yuri B Pride; Philip E Aylward; Jacques J Col; Shaun G Goodman; Dietrich Gulba; Mijo Bergovec; Vijayalakshmi Kunadian; Cafer Zorkun; Jacqueline Buros; Sabina A Murphy; Elliott M Antman
Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.
Journal of thrombosis and thrombolysis 2009;27(1):11-7.
2008: Shaheeda Ahmed; Christopher P Cannon; Robert P Giugliano; Sabina A Murphy; David A Morrow; Elliott M Antman; Eugene Braunwald; C Michael Gibson
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes.
International journal of cardiology 2008;131(1):105-12.
2008: Deepak L Bhatt; James M Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley; Robert A Harrington; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Mark A Hlatky; Sanjay Kaul; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Richard S Schofield; Robert S Rosenson; James H Stein; Howard H Weitz; Deborah J Wesley
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
The American journal of gastroenterology 2008;103(11):2890-907.
2008: Deepak L Bhatt; James M Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley; Robert A Harrington; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Mark A Hlatky; Sanjay Kaul; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Richard S Schofield; Robert S Rosenson; James H Stein; Howard H Weitz; Deborah J Wesley
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Journal of the American College of Cardiology 2008;52(18):1502-17.
2008: Deepak L Bhatt; James M Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Circulation 2008;118(18):1894-909.
2008: Stephen D Wiviott; Eugene Braunwald; Dominick J Angiolillo; Simha Meisel; Anthony J Dalby; Freek W A Verheugt; Shaun G Goodman; Ramon Corbalan; Drew A Purdy; Sabina A Murphy; Carolyn H McCabe; Elliott M Antman
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Circulation 2008;118(16):1626-36.
2008: Elliott M Antman
Time is muscle: translation into practice.
Journal of the American College of Cardiology 2008;52(15):1216-21.
2008: Elliott M Antman
The specialty of emergency medicine: needed now more than ever before.
Annals of emergency medicine 2008;52(4):317-9.
2008: Sabina A Murphy; Elliott M Antman; Stephen D Wiviott; Govinda Weerakkody; Giorgio Morocutti; Kurt Huber; Jose Lopez-Sendon; Carolyn H McCabe; Eugene Braunwald
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial.
European heart journal 2008;29(20):2473-9.
2008: Charles V Pollack; Elliott M Antman; Judd E Hollander
2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice.
Annals of emergency medicine 2008;52(4):344-355.e1.
2008: Elliott M Antman; David A Morrow
Biomarker release after percutaneous coronary intervention: a message from the heart.
Circulation. Cardiovascular interventions 2008;1(1):3-6.
2008: Steve Leung; Dianne Gallup; Kenneth W Mahaffey; Marc Cohen; Elliott M Antman; Shaun G Goodman; Robert A Harrington; Anatoly Langer; Philip Aylward; James J Ferguson; Robert M Califf
Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
American heart journal 2008;156(1):177-84.
2008: Niteesh K Choudhry; Troyen Brennan; Michele Toscano; Claire Spettell; Robert J Glynn; Mark Rubino; Sebastian Schneeweiss; Maurice Brookhart; Joaquim Fernandes; Susan Mathew; Blake Christiansen; Elliott M Antman; Jerry Avorn; William H Shrank
Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.
American heart journal 2008;156(1):31-6.
2008: Elliott M Antman; Stephen D Wiviott; Sabina A Murphy; Juri Voitk; Yonathan Hasin; Petr Widimsky; Harish Chandna; William Macias; Carolyn H McCabe; Eugene Braunwald
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Journal of the American College of Cardiology 2008;51(21):2028-33.
2008: Stephen D Wiviott; Eugene Braunwald; Sabina A Murphy; Elliott M Antman
A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38.
The American journal of cardiology 2008;101(9):1367-70.
2008: Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Ivan Horvath; Mátyás Keltai; Jean-Paul R Herrman; Frans Van de Werf; William E Downey; Benjamin M Scirica; Sabina A Murphy; Elliott M Antman
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Lancet 2008;371(9621):1353-63.
2008: Elliott M Antman
Is fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention?
Nature clinical practice. Cardiovascular medicine 2008;5(4):184-5.
2008: Niteesh K Choudhry; Amanda R Patrick; Elliott M Antman; Jerry Avorn; William H Shrank
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.
Circulation 2008;117(10):1261-8.
2008: Kenneth W Mahaffey; Qinghong Yang; Karen S Pieper; Elliott M Antman; Harvey D White; Shaun G Goodman; Marc Cohen; Neal S Kleiman; Anatoly Langer; Philip E G Aylward; Jacques J Col; Craig J Reist; James J Ferguson; Robert M Califf
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
Journal of general internal medicine 2008;23(3):310-6.
2008: Elliott M Antman; Mary Hand; Paul W Armstrong; Eric R Bates; Lee A Green; Lakshmi K Halasyamani; Judith S Hochman; Harlan Krumholz; Gervasio A Lamas; Charles J Mullany; David L Pearle; Michael A Sloan; Sidney C Smith; Daniel T Anbe; Frederick G Kushner; Joseph P Ornato; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon Ann Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee.
Circulation 2008;117(2):296-329.
2007: Stephen D Wiviott; Dietmar Trenk; Andrew L Frelinger; Michelle O'Donoghue; Franz-Josef Neumann; Alan D Michelson; Dominick J Angiolillo; Hanoch Hod; Gilles Montalescot; Debra L Miller; Joseph A Jakubowski; Richard Cairns; Sabina A Murphy; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Circulation 2007;116(25):2923-32.
2007: Robert W Yeh; Stephen D Wiviott; Robert P Giugliano; David A Morrow; Amy Shui; Jie Qin; Benjamin M Scirica; James E Bradner; Ik-Kyung Jang; C Michael Gibson; Elliott M Antman
Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes.
The American journal of cardiology 2007;100(12):1734-8.
2007: Pierluigi Tricoci; Yuliya Lokhnygina; Lisa G Berdan; Steven R Steinhubl; Dietrich C Gulba; Harvey D White; Neal S Kleiman; Philip E G Aylward; Anatoly Langer; Robert M Califf; James J Ferguson; Elliott M Antman; L Kristin Newby; Robert A Harrington; Shaun G Goodman; Kenneth W Mahaffey
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Circulation 2007;116(23):2669-77.
2007: David A Morrow; Elliott M Antman; Sabina A Murphy; Jie Qin; Mikhail Ruda; Sema Guneri; Ashok Joseph Jacob; Andrzej Budaj; Eugene Braunwald
Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
American heart journal 2007;154(6):1078-84, 1084.e1.
2007: Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda J Weerakkody; C Michael Gibson; Elliott M Antman
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
The New England journal of medicine 2007;357(20):2001-15.
2007: Christian T Ruff; Stephen D Wiviott; David A Morrow; Satishkumar Mohanavelu; Sabina A Murphy; Elliott M Antman; Eugene Braunwald
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction.
The American journal of medicine 2007;120(11):993-8.
2007: Benjamin M Scirica; David A Morrow; Zygmunt Sadowski; Mikhail Ruda; José Carlos Nicolau; Robert P Giugliano; Stephen D Wiviott; Marc S Sabatine; Amy Shui; Elliott M Antman; Eugene Braunwald
A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study.
European heart journal 2007;28(17):2070-6.
2007: Sabina A Murphy; Charles Michael Gibson; David A Morrow; Frans Van de Werf; Ian B Menown; Shaun G Goodman; Kenneth W Mahaffey; Marc Cohen; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
European heart journal 2007;28(17):2077-86.
2007: Sean M Donahoe; Garrick C Stewart; Carolyn H McCabe; Satishkumar Mohanavelu; Sabina A Murphy; Christopher P Cannon; Elliott M Antman
Diabetes and mortality following acute coronary syndromes.
JAMA : the journal of the American Medical Association 2007;298(7):765-75.
2007: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Journal of the American College of Cardiology 2007;50(7):e1-e157.
2007: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Circulation 2007;116(7):e148-304.
2007: Alice K Jacobs; Elliott M Antman; David P Faxon; Tammy Gregory; Penelope Solis
Development of systems of care for ST-elevation myocardial infarction patients: executive summary.
Circulation 2007;116(2):217-30.
2007: George Mensah; Mary M Hand; Elliott M Antman; Thomas Ryan; Robert Schriever; Sidney C Smith
Development of systems of care for ST-elevation myocardial infarction patients: the patient and public perspective.
Circulation 2007;116(2):e33-8.
2007: Benjamin A Steinberg; Nazanin Moghbeli; Jacqueline Buros; Mikhail Ruda; Alexander Parkhomenko; B Soma Raju; Armando García-Castillo; Marianna Janion; José Carlos Nicolau; Keith A A Fox; David A Morrow; C Michael Gibson; Elliott M Antman
Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.
American heart journal 2007;154(1):54-61.
2007: Roberto R Giraldez; José Carlos Nicolau; Ramon Corbalan; Enrique P Gurfinkel; Ursulo Juarez; Jose Lopez-Sendon; Alexander Parkhomenko; Peter Molhoek; Satishkumar Mohanavelu; David A Morrow; Elliott M Antman
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis.
European heart journal 2007;28(13):1566-73.
2007: Marc S Sabatine; David A Morrow; Anthony Dalby; Mathias Pfisterer; Tibor Duris; Jose Lopez-Sendon; Sabina A Murphy; Runlin Gao; Elliott M Antman; Eugene Braunwald
Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
Journal of the American College of Cardiology 2007;49(23):2256-63.
2007: Keith A A Fox; Elliott M Antman; Gilles Montalescot; Stefan Agewall; Bhupathi SomaRaju; Freek W A Verheugt; Jose Lopez-Sendon; Hanoch Hod; Sabina A Murphy; Eugene Braunwald
The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial.
Journal of the American College of Cardiology 2007;49(23):2249-55.
2007: C Michael Gibson; Sabina A Murphy; Gilles Montalescot; David A Morrow; Diego Ardissino; Marc Cohen; Dietrich C Gulba; Oscar H Kracoff; Basil S. Lewis; Nathan Roguin; Elliott M Antman; Eugene Braunwald
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Journal of the American College of Cardiology 2007;49(23):2238-46.
2007: Jessica L Mega; David A Morrow; Erika Ostör; Maria Dorobantu; Jie Qin; Elliott M Antman; Eugene Braunwald
Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction.
Circulation 2007;115(22):2822-8.
2007: Harvey D White; Eugene Braunwald; Sabina A Murphy; Ashok J Jacob; Nina Gotcheva; Leonid Polonetsky; Elliott M Antman
Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.
European heart journal 2007;28(9):1066-71.
2007: Chadwick D Miller; Anindita Banerjee; Kenneth W Mahaffey; Michael C Kontos; Gregory Fermann; Charles V Pollack; Elliott M Antman; Philip E G Aylward; Shaun G Goodman; Renato Santos; James J Ferguson; Robert M Califf; James W Hoekstra
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial.
European heart journal 2007;28(9):1079-84.
2007: Elliott M Antman; Joel S Bennett; Alan Daugherty; Curt D Furberg; Harold Roberts; Kathryn A Taubert
Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.
Circulation 2007;115(12):1634-42.
2007: Marc P Bonaca; Stephen D Wiviott; Marc S Sabatine; Jacqueline Buros; Sabina A Murphy; Benjamin M Scirica; Nader Rifai; Elliott M Antman; David A Morrow
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
The American journal of cardiology 2007;99(3):344-8.
2007: Niteesh K Choudhry; Jerry Avorn; Elliott M Antman; Sebastian Schneeweiss; William H Shrank
Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
Health affairs (Project Hope) 2007;26(1):186-94.
2007: Warren J Cantor; Kenneth W Mahaffey; Zhen Huang; Pranab Das; Dietrich C Gulba; Stanislav Glezer; Richard Gallo; John Ducas; Marc Cohen; Elliott M Antman; Anatoly Langer; Neal S Kleiman; Harvey D White; Robert J Chisholm; Robert A Harrington; James J Ferguson; Robert M Califf; Shaun G Goodman
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(1):73-83.
2006: Victor J Dzau; Elliott M Antman; Henry R Black; David L Hayes; JoAnn E Manson; Jorge Plutzky; Jeffrey J Popma; William Stevenson
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.
Circulation 2006;114(25):2871-91.
2006: Victor J Dzau; Elliott M Antman; Henry R Black; David L Hayes; JoAnn E Manson; Jorge Plutzky; Jeffrey J Popma; William Stevenson
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).
Circulation 2006;114(25):2850-70.
2006: Amy F Marple; Elliott M Antman; Mary M Hand
Cardiology patient pages. Modern treatment for heart attacks: opening blocked arteries quickly.
Circulation 2006;114(20):e578-80.
2006: Duane S Pinto; Ajay J Kirtane; Brahmajee K Nallamothu; Sabina A Murphy; David J Cohen; Roger J Laham; Donald E Cutlip; Eric R Bates; Paul D Frederick; Dave P Miller; Joseph P Carrozza; Elliott M Antman; Christopher P Cannon; C Michael Gibson
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.
Circulation 2006;114(19):2019-25.
2006: Marc Cohen; Kenneth W Mahaffey; Karen Pieper; Charles V Pollack; Elliott M Antman; James Hoekstra; Shaun G Goodman; Anatoly Langer; Jacques J Col; Harvey D White; Robert M Califf; James J Ferguson
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
Journal of the American College of Cardiology 2006;48(7):1346-54.
2006: Stephen D Wiviott; Elliott M Antman; C Michael Gibson; Gilles Montalescot; Jeffrey Riesmeyer; Govinda J Weerakkody; Kenneth J Winters; Jeffrey W Warmke; Carolyn H McCabe; Eugene Braunwald
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
American heart journal 2006;152(4):627-35.
2006: Dean J Kereiakes; Elliott M Antman
Clinical guidelines and practice: in search of the truth.
Journal of the American College of Cardiology 2006;48(6):1129-35; discussion 1136-8.
2006: Alan T Hirsch; Ziv Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon Ann Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations.
Journal of vascular and interventional radiology : JVIR 2006;17(9):1383-97; quiz 1398.
2006: Robert O Bonow; Blase A Carabello; Chatterjee Kanu; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce W Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
Circulation 2006;114(5):e84-231.
2006: Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
Journal of the American College of Cardiology 2006;48(3):e1-148.
2006: Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliot L Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy Kersten; Barbara Riegel; John F Robb; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.
Circulation 2006;113(22):2662-74.
2006: Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliot L Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy Kersten; Barbara Riegel; John F Robb; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.
Journal of the American College of Cardiology 2006;47(11):2343-55.
2006: Alice K Jacobs; Elliott M Antman; Gray Ellrodt; David P Faxon; Tammy Gregory; George Mensah; Peter Moyer; Joseph Ornato; eric peterson; Larry Sadwin; Sidney C Smith
Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention.
Circulation 2006;113(17):2152-63.
2006: Raphaëlle Dumaine; C Michael Gibson; Sabina A Murphy; Matthew C Southard; Hung Q Ly; Carolyn H McCabe; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(5):315-22.
2006: Stephen D Wiviott; David A Morrow; Paul D Frederick; Elliott M Antman; Eugene Braunwald
Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.
Journal of the American College of Cardiology 2006;47(8):1553-8.
2006: Elliott M Antman; David A Morrow; Carolyn H McCabe; Sabina A Murphy; Mikhail Ruda; Zygmunt Sadowski; Andrzej Budaj; Jose L López-Sendón; Sema Guneri; Frank Jiang; Harvey D White; Keith A A Fox; Eugene Braunwald
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.
The New England journal of medicine 2006;354(14):1477-88.
2006: Shaheeda Ahmed; Elliott M Antman; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Harvey White; David A Morrow; Eugene Braunwald
Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials).
Journal of thrombosis and thrombolysis 2006;21(2):119-29.
2006: Bernard J Gersh; Elliott M Antman
Selection of the optimal reperfusion strategy for STEMI: does time matter?
European heart journal 2006;27(7):761-3.
2006: Alan T Hirsch; Ziv Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon Ann Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
Circulation 2006;113(11):e463-654.
2006: Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neil; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).
Circulation 2006;113(7):e166-286.
2006: James L Januzzi; L Kristin Newby; Sabina A Murphy; Karen Pieper; Elliott M Antman; David A Morrow; Marc S Sabatine; Erik Ohman; Christopher P Cannon; Eugene Braunwald
Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
American heart journal 2006;151(2):360-6.
2006: Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).
Circulation 2006;113(1):156-75.
2006: Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).
Journal of the American College of Cardiology 2006;47(1):216-35.
2006: Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).
Journal of the American College of Cardiology 2006;47(1):e1-121.
2006: Marc S Sabatine; David A Morrow; Carolyn H McCabe; Elliott M Antman; C Michael Gibson; Christopher P Cannon
Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction.
American heart journal 2006;151(1):25-31.
2006: Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention).
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;67(1):87-112.
2005: Marc S Sabatine; David A Morrow; Gilles Montalescot; Mikael Dellborg; Jose L Leiva-Pons; Mátyás Keltai; Sabina A Murphy; Carolyn H McCabe; C Michael Gibson; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Circulation 2005;112(25):3846-54.
2005: Kenneth W Mahaffey; Marc Cohen; Jyotsna Garg; Elliott M Antman; Neal S Kleiman; Shaun G Goodman; Lisa G Berdan; Craig J Reist; Anatoly Langer; Harvey D White; Philip E G Aylward; Jacques J Col; James J Ferguson; Robert M Califf
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA : the journal of the American Medical Association 2005;294(20):2594-600.
2005: Frederick G Kushner; Elliott M Antman
Oral anticoagulation for atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice.
Circulation 2005;112(21):3212-4.
2005: Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.
Circulation 2005;112(12):e154-235.
2005: Elliott M Antman; David L DeMets; Joseph Loscalzo
Cyclooxygenase inhibition and cardiovascular risk.
Circulation 2005;112(5):759-70.
2005: Erik Ohman; Frans Van de Werf; Elliott M Antman; Robert M Califf; James A de Lemos; C Michael Gibson; Renee L Oliverio; Lynn Harrelson; Carolyn McCabe; Peter M DiBattiste; Eugene Braunwald
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial.
American heart journal 2005;150(1):79-88.
2005: Stephen D Wiviott; Elliott M Antman; Kenneth J Winters; Govinda J Weerakkody; Sabina A Murphy; Bruce D Behounek; Robert J Carney; Charles Lazzam; Raymond G McKay; Carolyn H McCabe; Eugene Braunwald
Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial.
Circulation 2005;111(25):3366-73.
2005: Jessica L Mega; David A Morrow; Marc S Sabatine; Xue-Qiao Zhao; Steven M Snapinn; Peter M DiBattiste; C Michael Gibson; Elliott M Antman; Eugene Braunwald; Pierre Théroux
Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.
American heart journal 2005;149(5):846-50.
2005: Giuseppe De Luca; Harry Suryapranata; Gregg W Stone; David Antoniucci; James E Tcheng; Franz-Josef Neumann; Frans Van de Werf; Elliott M Antman; Eric J Topol
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
JAMA : the journal of the American Medical Association 2005;293(14):1759-65.
2005: David A Morrow; Sabina A Murphy; Carolyn H McCabe; Nigel Mackman; Hing C Wong; Elliott M Antman
Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial.
European heart journal 2005;26(7):682-8.
2005: Jane A Leopold; Elliott M Antman
Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.
Circulation 2005;111(9):1097-9.
2005: Kausik K Ray; David A Morrow; C Michael Gibson; Sabina Murphy; Elliott M Antman; Eugene Braunwald
Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.
European heart journal 2005;26(5):440-6.
2005: Elliott M Antman; David A Morrow; Carolyn H McCabe; Frank Jiang; Harvey D White; Keith A A Fox; Divakar Sharma; Paul Chew; Eugene Braunwald
Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
American heart journal 2005;149(2):217-26.
2005: C Michael Gibson; Ajay J Kirtane; Keith Boundy; Hung Ly; Dimitrios Karmpaliotis; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.
Journal of the American College of Cardiology 2005;45(3):357-62.
2005: Hung Q Ly; Ajay J Kirtane; Jacqueline Buros; Robert P Giugliano; Jeffrey J Popma; Elliott M Antman; Robert A Harrington; Erik Ohman; C Michael Gibson
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction.
The American journal of cardiology 2005;95(3):383-6.
2005: Ajay J Kirtane; Ioanna Kosmidou; Dimitrios Karmpaliotis; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy.
The American journal of cardiology 2005;95(3):337-42.
2005: Ajay J Kirtane; Pedro Martinezclark; Aref M Rahman; Kausik K Ray; Dimitrios Karmpaliotis; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Matthew T Roe; Robert A Harrington; Erik Ohman; Eugene Braunwald; C Michael Gibson
Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2005;45(2):321-3.
2005: Amir Kashani; C Michael Gibson; Sabina A Murphy; Marc S Sabatine; David A Morrow; Elliott M Antman; Robert P Giugliano
Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction.
The American journal of cardiology 2005;95(2):228-33.
2005: Ajay J Kirtane; Aaron Weisbord; Dimitrios Karmpaliotis; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Erik Ohman; Matthew T Roe; Eugene Braunwald; C Michael Gibson
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.
The American journal of cardiology 2005;95(2):224-7.
2004: Howard A Cooper; Michael J Domanski; Yves Rosenberg; James Norman; Judith H Scott; Susan F Assmann; Sonja M McKinlay; Judith S Hochman; Elliott M Antman
Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial.
American heart journal 2004;148(6):1012-9.
2004: Michael J Domanski; Elliott M Antman; Sonja McKinlay; Sergei Varshavsky; Pyotr G Platonov; Susan F Assmann; James Norman
Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.
Controlled clinical trials 2004;25(6):553-62.
2004: Minang P Turakhia; Sabina A Murphy; Tina L Pinto; Elliott M Antman; Robert P Giugliano; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
The American journal of cardiology 2004;94(11):1406-10.
2004: C Michael Gibson; Raphaelle L Dumaine; Eli V Gelfand; Sabina A Murphy; David A Morrow; Stephen D Wiviott; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials.
European heart journal 2004;25(22):1998-2005.
2004: Dimitrios Karmpaliotis; Minang P Turakhia; Ajay J Kirtane; Sabina A Murphy; Ioanna Kosmidou; David A Morrow; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
The American journal of cardiology 2004;94(9):1113-7.
2004: Richard J Popp; Sidney C Smith; Rober J Adams; Elliott M Antman; Rae-Ellen W Kavey; Anthony N DeMaria; Erik Ohman; Bertram Pitt; James T Willerson; Buce J Bellande; Gregg C Fonarow; Rick A Nishimura; Pravin M Shah; John W Hirshfeld; Joseph V Messer; eric peterson; Eric N Prystowsky; Jeffrey L Anderson; Melvin D Cheitlin; Larry B Goldstein; Augustus O Grant; George A Beller; Edward F Hines; David Wm Livingston; Christine W McEntree
ACCF/AHA consensus conference report on professionalism and ethics.
Circulation 2004;110(16):2506-49.
2004: Joseph S Alpert; Kenneth I Shine; Robert J Adams; Elliott M Antman; Rae-Ellen W Kavey; Lawrence Friedman; Robert L Frye; Robert A Harrington; David Korn; Jon F Merz; Elizabeth Ofili
Task force 1: The ACCF and AHA codes of conduct in human subjects research.
Journal of the American College of Cardiology 2004;44(8):1724-8.
2004: Amir Kashani; Robert P Giugliano; Elliott M Antman; David A Morrow; C Michael Gibson; Sabina A Murphy; Eugene Braunwald
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction.
European heart journal 2004;25(19):1702-10.
2004: David A Morrow; Marc S Sabatine; Elliott M Antman; Christopher P Cannon; Eugene Braunwald; Pierre Theroux
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS).
The American journal of cardiology 2004;94(6):774-6.
2004: Brahmajee K Nallamothu; Elliott M Antman; Eric R Bates
Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?
The American journal of cardiology 2004;94(6):772-4.
2004: Kim A Eagle; Robert A Guyton; Ravin Davidoff; Fred H Edwards; Gordon A Ewy; Timothy J Gardner; James C Hart; Howard C Herrmann; L David Hillis; Adolph M Hutter; Bruce W Lytle; Robert A Marlow; William C Nugent; Thomas A Orszulak; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Joseph P Ornato
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).
Journal of the American College of Cardiology 2004;44(5):e213-310.
2004: C Michael Gibson; Sabina A Murphy; Ajay J Kirtane; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(5):980-7.
2004: Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).
Circulation 2004;110(9):e82-292.
2004: Kim A Eagle; Robert A Guyton; Ravin Davidoff; Fred H Edwards; Gordon A Ewy; Timothy J Gardner; James C Hart; Howard C Herrmann; L David Hillis; Adolph M Hutter; Bruce W Lytle; Robert A Marlow; William C Nugent; Thomas A Orszulak; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Joseph P Ornato
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).
Circulation 2004;110(9):1168-76.
2004: Stephen D Wiviott; David A Morrow; Paul D Frederick; Robert P Giugliano; C Michael Gibson; Carolyn H McCabe; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(4):783-9.
2004: Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).
Journal of the American College of Cardiology 2004;44(3):671-719.
2004: Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).
Circulation 2004;110(5):588-636.
2004: Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).
The Canadian journal of cardiology 2004;20(10):977-1025.
2004: C Michael Gibson; Sabina A Murphy; David A Morrow; Julian M Aroesty; Raymond J Gibbons; Steven G Gourlay; Hal V Barron; Robert P Giugliano; Elliott M Antman; Eugene Braunwald
Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.
American heart journal 2004;148(2):336-40.
2004: Jessica L Mega; David A Morrow; James A De Lemos; Marc S Sabatine; Sabina A Murphy; Nader Rifai; C Michael Gibson; Elliott M Antman; Eugene Braunwald
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Journal of the American College of Cardiology 2004;44(2):335-9.
2004: Graham S Gardner; Daniel R Frisch; Sabina A Murphy; Ajay J Kirtane; Robert P Giugliano; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries.
The American journal of cardiology 2004;94(2):178-81.
2004: John L Petersen; Kenneth W Mahaffey; Vic Hasselblad; Elliott M Antman; Marc Cohen; Shaun G Goodman; Anatoly Langer; Michael A Blazing; Anne Le-Moigne-Amrani; James A de Lemos; Christopher C. Nessel; Robert A Harrington; James J Ferguson; Eugene Braunwald; Robert M Califf
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
JAMA : the journal of the American Medical Association 2004;292(1):89-96.
2004: David A Morrow; Elliott M Antman; Sabina A Murphy; Susan F Assmann; Robert P Giugliano; Christopher P Cannon; C Michael Gibson; Carolyn H McCabe; Hal V Barron; Frans Van de Werf; Eugene Braunwald
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies.
European heart journal 2004;25(13):1139-45.
2004: C Michael Gibson; Brian Bigelow; David James; Micah R Tepper; Sabina A Murphy; Ajay J Kirtane; Robert P Giugliano; Christopher P Cannon; Elliott M Antman
Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction.
The American journal of cardiology 2004;94(1):108-11.
2004: John V Wylie; Sabina A Murphy; David A Morrow; James A de Lemos; Elliott M Antman; Christopher P Cannon
Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.
American heart journal 2004;148(1):173-80.
2004: Stephen D Wiviott; Elliott M Antman
Clopidogrel resistance: a new chapter in a fast-moving story.
Circulation 2004;109(25):3064-7.
2004: Ajay J Kirtane; Anh Bui; Sabina A Murphy; Dimitrios Karmpaliotis; Ioanna Kosmidou; Keith Boundy; Aref Rahman; Duane S Pinto; Julian M Aroesty; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; C Michael Gibson
Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction.
Journal of thrombosis and thrombolysis 2004;17(3):177-84.
2004: C Michael Gibson; James A de Lemos; Elliott M Antman
Time is muscle in primary PCI: the strength of the evidence grows.
European heart journal 2004;25(12):1001-2.
2004: Elliott M Antman; Frans Van de Werf
Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
Circulation 2004;109(21):2480-6.
2004: Robert P Giugliano; Marc S Sabatine; C Michael Gibson; Matthew T Roe; Robert A Harrington; Sabina A Murphy; David A Morrow; Elliott M Antman; Eugene Braunwald
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion.
The American journal of cardiology 2004;93(11):1362-7, A5-6.
2004: Masahisa Shimpo; David A Morrow; Ellen O Weinberg; Marc S Sabatine; Sabina A Murphy; Elliott M Antman; Richard T Lee
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction.
Circulation 2004;109(18):2186-90.
2004: C Michael Gibson; Juhana Karha; Sabina A Murphy; James A de Lemos; David A Morrow; Robert P Giugliano; Matthew T Roe; Robert A Harrington; Christopher P Cannon; Elliott M Antman; Robert M Califf; Eugene Braunwald
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.
Journal of the American College of Cardiology 2004;43(7):1170-6.
2004: Anthony A Bavry; Dharam J Kumbhani; Rene Quiroz; Suneil R Ramchandani; Satish Kenchaiah; Elliott M Antman
Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.
The American journal of cardiology 2004;93(7):830-5.
2004: Giuseppe De Luca; Harry Suryapranata; Jan Paul Ottervanger; Elliott M Antman
Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.
Circulation 2004;109(10):1223-5.
2004: Marc S Sabatine; David A Morrow; Robert P Giugliano; Sabina A Murphy; Laura A Demopoulos; Peter M DiBattiste; William S Weintraub; Carolyn H McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Circulation 2004;109(7):874-80.
2004: Stephen D Wiviott; Christopher P Cannon; David A Morrow; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Marc S Sabatine; Nader Rifai; Robert P Giugliano; Peter M DiBattiste; Laura A Demopoulos; Elliott M Antman; Eugene Braunwald
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
Circulation 2004;109(5):580-6.
2004: Kenneth M Kessler; Raymond J Gibbons; Sidney C Smith; Elliott M Antman
All opinions are not equal.
Circulation 2004;109(3):E21.
2004: Elliott M Antman
Coronary care medicine: it's not your father's CCU anymore.
Transactions of the American Clinical and Climatological Association 2004;115():123-34; discussion 134-5.
2003: Paul W Armstrong; Elliott M Antman
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.
The New England journal of medicine 2003;349(22):2167-9; author reply 2167-9.
2003: Elliott M Antman; James J Ferguson
Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents?
Circulation 2003;108(21):2604-7.
2003: C Michael Gibson; Duane S Pinto; Sabina A Murphy; David A Morrow; Hans-Peter Hobbach; Stephen D Wiviott; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality.
Journal of the American College of Cardiology 2003;42(9):1535-43.
2003: Aloke V Finn; Elliott M Antman
Images in clinical medicine. Isolated right ventricular infarction.
The New England journal of medicine 2003;349(17):1636.
2003: Juhana Karha; Sabina A Murphy; Ajay J Kirtane; James A de Lemos; Julian M Aroesty; Christopher P Cannon; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction.
The American journal of cardiology 2003;92(8):913-8.
2003: Melvin D Cheitlin; William F Armstrong; Gerard P Aurigemma; George A Beller; Fredrick Bierman; Jack L Davis; Pamela S Douglas; David P Faxon; Linda D Gillam; Thomas R Kimball; William G Kussmaul; Alan S Pearlman; John T Philbrick; Harry Rakowski; Daniel M Thys; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2003;16(10):1091-110.
2003: James J Ferguson; Elliott M Antman; Eric R Bates; Marc Cohen; Nathan R Every; Robert A Harrington; Carl J Pepine; Pierre Theroux
Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
American heart journal 2003;146(4):628-34.
2003: Elliott M Antman
Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
American heart journal 2003;146(4 Suppl):S18-22.
2003: Francis J Klocke; Michael G Baird; Beverly H Lorell; Timothy M Bateman; Joseph V Messer; Daniel S Berman; Patrick T O'Gara; Blase A Carabello; Richard O Russell; Manuel D Cerqueira; Martin St John Sutton; Anthony N DeMaria; James E Udelson; J Ward Kennedy; Mario S Verani; Kim Allan Williams; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).
Journal of the American College of Cardiology 2003;42(7):1318-33.
2003: René Bruno; Pascale Baille; Sylvie Retout; Nicole Vivier; Christine Veyrat-Follet; Ger-Jan Sanderink; Richard Becker; Elliott M Antman
Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction.
British journal of clinical pharmacology 2003;56(4):407-14.
2003: Francis J Klocke; Michael G Baird; Beverly H Lorell; Timothy M Bateman; Joseph V Messer; Daniel S Berman; Patrick T O'Gara; Blase A Carabello; Richard O Russell; Manuel D Cerqueira; Martin St John Sutton; Anthony N DeMaria; James E Udelson; J Ward Kennedy; Mario S Verani; Kim Allan Williams; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).
Circulation 2003;108(11):1404-18.
2003: Melvin D Cheitlin; William F Armstrong; Gerard P Aurigemma; George A Beller; Fredrick Bierman; Jack L Davis; Pamela S Douglas; David P Faxon; Linda D Gillam; Thomas R Kimball; William G Kussmaul; Alan S Pearlman; John T Philbrick; Harry Rakowski; Daniel M Thys; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).
Circulation 2003;108(9):1146-62.
2003: C Michael Gibson; William Gibson; Sabina A Murphy; Susan J Marble; Carolyn H McCabe; Minang P Turakhia; Ajay J Kirtane; Juhana Karha; Julian M Aroesty; Robert P Giugliano; Elliott M Antman
Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction.
The American journal of cardiology 2003;92(5):595-7.
2003: Elliott M Antman
Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on.
American heart journal 2003;146(2):191-3.
2003: C Michael Gibson; Juhana Karha; Sabina A Murphy; David James; David A Morrow; Christopher P Cannon; Robert P Giugliano; Elliott M Antman; Eugene Braunwald
Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials.
Journal of the American College of Cardiology 2003;42(1):7-16.
2003: Sabina A Murphy; Kent W Dauterman; James A de Lemos; Sarah Kermgard; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
American heart journal 2003;146(1):42-7.
2003: Sarah A Spinler; Stephanie M Inverso; Marc Cohen; Shaun G Goodman; Kathleen A Stringer; Elliott M Antman
Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.
American heart journal 2003;146(1):33-41.
2003: Raymond J Gibbons; Sidney C Smith; Elliott M Antman
American College of Cardiology/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project.
Circulation 2003;107(24):3101-7.
2003: Raymond J Gibbons; Sidney Smith; Elliott M Antman
American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?
Circulation 2003;107(23):2979-86.
2003: C Michael Gibson; Ajay J Kirtane; Sabina A Murphy; Juhana Karha; Christopher P Cannon; Robert P Giugliano; Matthew T Roe; Robert A Harrington; Erik Ohman; Elliott M Antman
Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture.
Journal of thrombosis and thrombolysis 2003;15(3):189-96.
2003: Paul W Armstrong; Désiré Collen; Elliott M Antman
Fibrinolysis for acute myocardial infarction: the future is here and now.
Circulation 2003;107(20):2533-7.
2003: David A Morrow; James A de Lemos; Marc S Sabatine; Elliott M Antman
The search for a biomarker of cardiac ischemia.
Clinical chemistry 2003;49(4):537-9.
2003: Marc S Sabatine; Elliott M Antman
The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2003;41(4 Suppl S):89S-95S.
2003: Elliott M Antman
Should bivalirudin replace heparin during percutaneous coronary interventions?
JAMA : the journal of the American Medical Association 2003;289(7):903-5.
2003: James A de Lemos; David A Morrow; Marc S Sabatine; Sabina A Murphy; C Michael Gibson; Elliott M Antman; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Circulation 2003;107(5):690-5.
2003: Elliott M Antman
[Present and future of antithrombotic therapy in acute coronary syndromes].
Revista española de cardiología 2003;56(2):115-20.
2003: Graham C Wong; Robert P Giugliano; Elliott M Antman
Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.
JAMA : the journal of the American Medical Association 2003;289(3):331-42.
2003: Raymond J Gibbons; Jonathan Abrams; Kanu Chatterjee; Jennifer Daley; Prakash C Deedwania; John S Douglas; T. Bruce Ferguson; Stephan D Fihn; Theodore D Fraker; Julius M Gardin; Robert A O'Rourke; Richard C Pasternak; Sankey V Williams; Raymond J Gibbons; Joseph S Alpert; Elliott M Antman; Loren F Hiratzka; Valentin Fuster; David P Faxon; Gabriel Gregoratos; Alice K Jacobs; Sidney C Smith
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).
Circulation 2003;107(1):149-58.
2003: Maria Cecilia Bahit; Christopher P Cannon; Elliott M Antman; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Eugene Braunwald
Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry.
American heart journal 2003;145(1):109-17.
2002: C Michael Gibson; James A de Lemos; Sabina A Murphy; Susan J Marble; Kent W Dauterman; Andrew D Michaels; Hal V Barron; Elliott M Antman
Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction.
Journal of thrombosis and thrombolysis 2002;14(3):233-7.
2002: Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond I Gibbons; Elliott M Antman; Joseph S Alpert; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
Journal of cardiovascular electrophysiology 2002;13(11):1183-99.
2002: Marc Cohen; Elliott M Antman
Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation.
Thrombosis and haemostasis 2002;88(5):884-6; 886-7.
2002: Howard A Cooper; James A de Lemos; David A Morrow; Marc S Sabatine; Sabina A Murphy; Carolyn H McCabe; C Michael Gibson; Elliott M Antman; Eugene Braunwald
Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration.
American heart journal 2002;144(5):790-5.
2002: Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).
Journal of the American College of Cardiology 2002;40(8):1531-40.
2002: Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; Gabriel Gregoratos; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
Circulation 2002;106(16):2145-61.
2002: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean J Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology 2002;40(7):1366-74.
2002: Brad G Angeja; James de Lemos; Sabina A Murphy; Susan J Marble; Elliott M Antman; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy.
American heart journal 2002;144(4):649-56.
2002: Dean J Kereiakes; Gilles Montalescot; Elliott M Antman; Marc Cohen; Harald Darius; James J Ferguson; Cindy L Grines; Karl R Karsch; Neal S Kleiman; David J Moliterno; Philippe Gabriel STEG; Paul Teirstein; Frans Van de Werf; Lars Wallentin
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus.
American heart journal 2002;144(4):615-24.
2002: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean J Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Circulation 2002;106(14):1893-900.
2002: Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith
ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).
Circulation 2002;106(14):1883-92.
2002: Sabina A Murphy; Christopher Chen; Christopher P Cannon; Elliott M Antman; C Michael Gibson
Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction.
The American journal of cardiology 2002;90(7):766-70.
2002: Keith A A Fox; Elliott M Antman; Marc Cohen; Frederique Bigonzi
Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention.
The American journal of cardiology 2002;90(5):477-82.
2002: Benjamin M Scirica; Christopher P Cannon; Elliott M Antman; Sabina A Murphy; David A Morrow; Marc S Sabatine; Carolyn H McCabe; C Michael Gibson; Eugene Braunwald
Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry.
The American journal of cardiology 2002;90(3):303-5.
2002: James A de Lemos; David A Morrow; C Michael Gibson; Sabina A Murphy; Marc S Sabatine; Nader Rifai; Carolyn H McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies.
Journal of the American College of Cardiology 2002;40(2):238-44.
2002: David A Morrow; Elliott M Antman; Assaad Sayah; Kristin C Schuhwerk; Robert P Giugliano; James A deLemos; Michael Waller; Sidney A Cohen; Donald G Rosenberg; Sally S Cutler; Carolyn H McCabe; Ron M Walls; Eugene Braunwald
Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial.
Journal of the American College of Cardiology 2002;40(1):71-7.
2002: Elliott M Antman
Decision making with cardiac troponin tests.
The New England journal of medicine 2002;346(26):2079-82.
2002: Brad G Angeja; Sarah Kermgard; Michael S Chen; Matthew McKay; Sabina A Murphy; Elliott M Antman; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
The smoker's paradox: insights from the angiographic substudies of the TIMI trials.
Journal of thrombosis and thrombolysis 2002;13(3):133-9.
2002: Marc S Sabatine; Carolyn H McCabe; David A Morrow; Robert P Giugliano; James A de Lemos; Marc Cohen; Elliott M Antman; Eugene Braunwald
Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.
American heart journal 2002;143(6):966-70.
2002: Elliott M Antman; Howard A Cooper; C Michael Gibson; James A de Lemos; Carolyn H McCabe; Robert P Giugliano; P Coussement; S Murphy; J Scherer; K Anderson; Frans Van de Werf; Eugene Braunwald
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.
European heart journal 2002;23(12):928-33.
2002: Richard C Becker; Frederick A Spencer; Michael Gibson; Janet E Rush; Gerard Sanderink; Sabina A Murphy; Steven P Ball; Elliott M Antman
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes.
American heart journal 2002;143(5):753-9.
2002: Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
Anesthesia and analgesia 2002;94(5):1052-64.
2002: Marc S Sabatine; David A Morrow; James A de Lemos; C Michael Gibson; Sabina A Murphy; Nader Rifai; Carolyn McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
Circulation 2002;105(15):1760-3.
2002: Elliott M Antman; Hans W Louwerenburg; Hubert F Baars; Jan C L Wesdorp; Bas Hamer; Jean-Pierre Bassand; Frederique Bigonzi; Ghislaine Pisapia; C Michael Gibson; Hein Heidbuchel; Eugene Braunwald; Frans Van de Werf
Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
Circulation 2002;105(14):1642-9.
2002: Marc Cohen; Elliott M Antman
Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes.
Pharmacotherapy 2002;22(4):542-6; author reply 546-50.
2002: Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
Circulation 2002;105(10):1257-67.
2002: Christopher P Cannon; Maria Cecilia Bahit; J Mark Haugland; Timothy D Henry; Marc J Schweiger; George R McKendall; Prediman K Shah; Sabina Murphy; C Michael Gibson; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry.
Critical pathways in cardiology 2002;1(1):44-52.
2002: Torbjørn Omland; James A de Lemos; David A Morrow; Elliott M Antman; Christopher P Cannon; Christian Hall; Eugene Braunwald
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes.
The American journal of cardiology 2002;89(4):463-5.
2002: Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
Journal of the American College of Cardiology 2002;39(3):542-53.
2002: Elliott M Antman; Carolyn H McCabe; Eugene Braunwald
Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.
American heart journal 2002;143(2):229-34.
2002: Sharon Ann Hunt; David W Baker; Marshall H Chin; Michael P Cinquegrani; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Sidney Goldstein; Gabriel Gregoratos; Mariell Jessup; R Joseph Noble; Milton Packer; Marc A Silver; Lynne Warner Stevenson; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2002;21(2):189-203.
2002: Elliott M Antman; Marc Cohen; Carolyn McCabe; S G Goodman; Sabina A Murphy; Eugene Braunwald
Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE.
European heart journal 2002;23(4):308-14.
2002: David A Morrow; Elliott M Antman; Steven M Snapinn; Carolyn H McCabe; Pierre Theroux; Eugene Braunwald
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.
European heart journal 2002;23(3):223-9.
2002: Marc Cohen; Elliott M Antman; Sabina A Murphy; David Radley
Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes.
American heart journal 2002;143(1):63-9.
2001: Sharon Ann Hunt; D W Baker; Marshall H Chin; Michael P Cinquegrani; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Sidney Goldstein; Gabriel Gregoratos; Mariell Jessup; R Joseph Noble; Milton Packer; Marc A Silver; Lynne Warner Stevenson; R J Gibbons; Elliott M Antman; J S Alpert; David P Faxon; Valentin Fuster; G Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.
Circulation 2001;104(24):2996-3007.
2001: Marc Cohen; Elliott M Antman; Enrique P Gurfinkel; David Radley
Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups.
Journal of thrombosis and thrombolysis 2001;12(3):199-206.
2001: Sharon Ann Hunt; D W Baker; M H Chin; Michael P Cinquegrani; Arthur M Feldman; G S Francis; Theodore G Ganiats; Sidney Goldstein; Gabriel Gregoratos; Mariell Jessup; R Joseph Noble; Milton Packer; M A Silver; Lynne Warner Stevenson; R J Gibbons; Elliott M Antman; J S Alpert; David P Faxon; Valentin Fuster; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).
Journal of the American College of Cardiology 2001;38(7):2101-13.
2001: David A Morrow; Elliott M Antman; Robert P Giugliano; Richard Cairns; A Charlesworth; Sabina A Murphy; James A de Lemos; Carolyn H McCabe; Eugene Braunwald
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy.
Lancet 2001;358(9293):1571-5.
2001: J Llevadot; Robert P Giugliano; Elliott M Antman; Robert G Wilcox; Enrique P Gurfinkel; T Henry; Carolyn H McCabe; A Charlesworth; S Thompson; José Carlos Nicolau; U Tebbe; Zygmunt Sadowski; Eugene Braunwald
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction.
European heart journal 2001;22(22):2104-15.
2001: David A Morrow; Elliott M Antman; L Parsons; James A de Lemos; Christopher P Cannon; Robert P Giugliano; Carolyn H McCabe; H V Barron; Eugene Braunwald
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3.
JAMA : the journal of the American Medical Association 2001;286(11):1356-9.
2001: Robert P Giugliano; J Llevadot; Robert G Wilcox; Enrique P Gurfinkel; Carolyn H McCabe; A Charlesworth; S L Thompson; Elliott M Antman; Eugene Braunwald
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II.
European heart journal 2001;22(18):1702-15.
2001: James A de Lemos; David A Morrow; C Michael Gibson; Sabina A Murphy; Nader Rifai; M Tanasijevic; Robert P Giugliano; Kristin C Schuhwerk; Carolyn H McCabe; C P Cannon; Elliott M Antman; Eugene Braunwald
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy.
The American journal of cardiology 2001;88(4):353-8.
2001: J Llevadot; Robert P Giugliano; Elliott M Antman
Bolus fibrinolytic therapy in acute myocardial infarction.
JAMA : the journal of the American Medical Association 2001;286(4):442-9.
2001: Elliott M Antman
Clinical trials in cardiovascular medicine.
Circulation 2001;103(21):E101-4.
2001: Elliott M Antman
The search for replacements for unfractionated heparin.
Circulation 2001;103(18):2310-4.
2001: Robert P Giugliano; Carolyn H McCabe; Elliott M Antman; Christopher P Cannon; Frans Van de Werf; R G Wilcox; Eugene Braunwald
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
American heart journal 2001;141(5):742-50.
2001: E M Holper; Elliott M Antman; Carolyn H McCabe; J Premmereur; Enrique P Gurfinkel; PJ Bernink; Alexander G G Turpie; Antoni Bayes-de-Luna; J M Lablanche; K M Fox; D Salein; David Radley; Eugene Braunwald
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.
The American journal of cardiology 2001;87(8):1008-10; A5.
2001: James A de Lemos; C Michael Gibson; Elliott M Antman; Sabina A Murphy; David A Morrow; Kristin C Schuhwerk; M Schweiger; P Coussement; Frans Van de Werf; Eugene Braunwald
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
American heart journal 2001;141(4):592-8.
2001: Jose Santopinto; Enrique P Gurfinkel; V Torres; E Marcos; Gerardo E Bozovich; Branco Mautner; Carolyn H McCabe; Elliott M Antman
Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
American heart journal 2001;141(4):566-72.
2000: C Michael Gibson; M Anshelevich; S Murphy; L Luu; C Hynes; J Kliris; S Kermgard; M H Otten; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.
The American journal of cardiology 2000;86(12):1378-9, A5.
2000: James A de Lemos; Elliott M Antman; Robert P Giugliano; David A Morrow; Carolyn H McCabe; S S Cutler; A Charlesworth; R Schröder; Eugene Braunwald
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II.
The American journal of cardiology 2000;86(11):1235-7, A5.
2000: Elliott M Antman; C Michael Gibson; James A de Lemos; Robert P Giugliano; Carolyn H McCabe; P Coussement; Ian B A Menown; Christoph A Nienaber; T C Rehders; MJ Frey; R Van der Wieken; Dietrich Andresen; J Scherer; K Anderson; Frans Van de Werf; Eugene Braunwald
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.
European heart journal 2000;21(23):1944-53.
2000: David A Morrow; Elliott M Antman; Milenko J Tanasijevic; Nader Rifai; James A de Lemos; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.
Journal of the American College of Cardiology 2000;36(6):1812-7.
2000: David A Morrow; Elliott M Antman; A Charlesworth; Richard Cairns; Sabina A Murphy; James A de Lemos; Robert P Giugliano; Carolyn H McCabe; Eugene Braunwald
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy.
Circulation 2000;102(17):2031-7.
2000: Gerardo E Bozovich; Enrique P Gurfinkel; Elliott M Antman; Carolyn H McCabe; Branco Mautner
Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time.
American heart journal 2000;140(4):637-42.
2000: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean J Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; Kim A Eagle; David P Faxon; Valentin Fuster; Timothy J Gardner; Gabriel Gregoratos; Richard O Russell; Sidney C Smith
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).
Circulation 2000;102(10):1193-209.
2000: Marc Cohen; Elliott M Antman; Enrique P Gurfinkel; Alexander G G Turpie; J Furst; Frederique Bigonzi; David Radley
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction.
The American journal of cardiology 2000;86(5):553-6, A9.
2000: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean J Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Joseph S Alpert; Kim A Eagle; David P Faxon; Valentin Fuster; Timothy J Gardner; Gabriel Gregoratos; Richard O Russell; Sidney C Smith
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology 2000;36(3):970-1062.
2000: James A de Lemos; Elliott M Antman; Robert P Giugliano; David A Morrow; Carolyn H McCabe; A Charlesworth; R Schröder; Eugene Braunwald
Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram.
American heart journal 2000;140(3):373-8.
2000: Elliott M Antman; Marc Cohen; PJ Bernink; Carolyn H McCabe; T Horacek; G Papuchis; Branco Mautner; R Corbalan; David Radley; Eugene Braunwald
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.
JAMA : the journal of the American Medical Association 2000;284(7):835-42.
2000: James A de Lemos; Elliott M Antman; David A Morrow; J Llevadot; Robert P Giugliano; SA Coulter; Kristin C Schuhwerk; S Arslanian; Carolyn H McCabe; C Michael Gibson; Nader Rifai
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.
Clinica chimica acta; international journal of clinical chemistry 2000;298(1-2):85-97.
2000: J Llevadot; Robert P Giugliano; Carolyn H McCabe; Christopher P Cannon; Elliott M Antman; S Murphy; C Michael Gibson
Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials).
The American journal of cardiology 2000;85(12):1409-13.
2000: SA Coulter; Christopher P Cannon; K A Ault; Elliott M Antman; Frans Van de Werf; A A Jennifer Adgey; C Michael Gibson; Robert P Giugliano; Mary Ann Mascelli; J Scherer; Elliot S Barnathan; Eugene Braunwald; N S Kleiman
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.
Circulation 2000;101(23):2690-5.
2000: David A Morrow; Nader Rifai; Milenko J Tanasijevic; DR Wybenga; James A de Lemos; Elliott M Antman
Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy.
Clinical chemistry 2000;46(4):453-60.
2000: Elliott M Antman; K M Fox
Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum.
American heart journal 2000;139(3):461-75.
2000: James A de Lemos; Elliott M Antman; Robert P Giugliano; Carolyn H McCabe; Sabina A Murphy; Frans Van de Werf; C Michael Gibson; Eugene Braunwald
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators.
The American journal of cardiology 2000;85(3):299-304.
2000: David A Morrow; Nader Rifai; Elliott M Antman; D L Weiner; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy.
Journal of the American College of Cardiology 2000;35(2):358-62.
2000: James A de Lemos; Elliott M Antman; C Michael Gibson; Carolyn H McCabe; Robert P Giugliano; Sabina A Murphy; SA Coulter; K Anderson; J Scherer; MJ Frey; R Van der Wieken; Frans Van de Werf; Eugene Braunwald
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.
Circulation 2000;101(3):239-43.
1999: E M Holper; Robert P Giugliano; Elliott M Antman
Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction.
Coronary artery disease 1999;10(8):567-73.
1999: Elliott M Antman; M Cohen
Newer antithrombin agents in acute coronary syndromes.
American heart journal 1999;138(6 Pt 2):S563-9.
1999: C Michael Gibson; S Murphy; Ian B A Menown; Rafael Sequeira; R Greene; Frans Van de Werf; M J Schweiger; M Ghali; MJ Frey; KA Ryan; Susan J Marble; Robert P Giugliano; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.
Journal of the American College of Cardiology 1999;34(5):1403-12.
1999: Elliott M Antman; Marc Cohen; David Radley; Carolyn McCabe; J Rush; J Premmereur; Eugene Braunwald
Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis.
Circulation 1999;100(15):1602-8.
1999: Elliott M Antman; Carolyn H McCabe; Enrique P Gurfinkel; Alexander G G Turpie; PJ Bernink; D Salein; Antoni Bayes-de-Luna; K Fox; J M Lablanche; David Radley; J Premmereur; Eugene Braunwald
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
Circulation 1999;100(15):1593-601.
1999: C Michael Gibson; KA Ryan; Sabina A Murphy; R Mesley; Susan J Marble; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.
Journal of the American College of Cardiology 1999;34(4):974-82.
1999: Paul M Ridker; Elliott M Antman
Pathogenesis and pathology of coronary heart disease syndromes.
Journal of thrombosis and thrombolysis 1999;8(3):167-89.
1999: Thomas Ryan; Elliott M Antman; N H Brooks; Robert M Califf; L David Hillis; Loren F Hiratzka; E Rapaport; B Riegel; Richard O Russell; E E Smith; W D Weaver; Raymond J Gibbons; Joseph S Alpert; Kim A Eagle; Timothy J Gardner; Arthur Garson; Gabriel Gregoratos; T J Ryan; Sidney C Smith
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Journal of the American College of Cardiology 1999;34(3):890-911.
1999: Milenko J Tanasijevic; Christopher P Cannon; Elliott M Antman; DR Wybenga; George A Fischer; C Grudzien; C Michael Gibson; James W Winkelman; Eugene Braunwald
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
Journal of the American College of Cardiology 1999;34(3):739-47.
1999: Thomas Ryan; Elliott M Antman; N H Brooks; Robert M Califf; L David Hillis; Loren F Hiratzka; E Rapaport; B Riegel; Richard O Russell; E E Smith; W D Weaver; Raymond J Gibbons; Joseph S Alpert; Kim A Eagle; Timothy J Gardner; Arthur Garson; Gabriel Gregoratos; Sidney C Smith
1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Circulation 1999;100(9):1016-30.
1999: Elliott M Antman; Robert P Giugliano; C Michael Gibson; Carolyn H McCabe; P Coussement; N S Kleiman; A Vahanian; A A Jennifer Adgey; Ian B A Menown; H J Rupprecht; R Van der Wieken; J Ducas; J Scherer; K Anderson; Frans Van de Werf; Eugene Braunwald
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.
Circulation 1999;99(21):2720-32.
1999: C Michael Gibson; KA Ryan; M Kelley; MJ Rizzo; R Mesley; S Murphy; J Swanson; Susan J Marble; J Theodore Dodge; Robert P Giugliano; Christopher P Cannon; Elliott M Antman
Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group.
American heart journal 1999;137(6):1179-84.
1999: Richard C Becker; Judith S Hochman; C P Cannon; Frederick A Spencer; Steven P Ball; M J Rizzo; Elliott M Antman
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study.
Journal of the American College of Cardiology 1999;33(2):479-87.
1999: Milenko J Tanasijevic; Christopher P Cannon; Elliott M Antman
The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease.
Clinical cardiology 1999;22(1):13-6.
1998: SC Reimold; William H Maisel; Elliott M Antman
Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis.
The American journal of cardiology 1998;82(8A):66N-71N.
1998: Keith A A Fox; Elliott M Antman
Treatment options in unstable angina: a clinical update.
European heart journal 1998;19 Suppl K():K8-10.
1998: Elliott M Antman
TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators.
American heart journal 1998;135(6 Pt 3 Su):S353-60.
1998: David A Morrow; Nader Rifai; Elliott M Antman; D L Weiner; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.
Journal of the American College of Cardiology 1998;31(7):1460-5.
1998: Elliott M Antman; DB Sacks; Nader Rifai; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy.
Journal of the American College of Cardiology 1998;31(2):326-30.
1997: C Michael Gibson; J Theodore Dodge; M Goel; EN Al-Mousa; M Rizzo; C McLean; K Ryan; A Sparano; Susan J Marble; W L Daley; Christopher P Cannon; Elliott M Antman
Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow.
The American journal of cardiology 1997;80(12):1536-9.
1997: G Nichol; R Walls; L Goldman; S Pearson; L H Hartley; Elliott M Antman; M Stockman; J M Teich; C P Cannon; P A Johnson; K M Kuntz; T H Lee
A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impact.
Annals of internal medicine 1997;127(11):996-1005.
1997: L I Ganz; Elliott M Antman
Antiarrhythmic drug therapy in the management of atrial fibrillation.
Journal of cardiovascular electrophysiology 1997;8(10):1175-89.
1997: Milenko J Tanasijevic; Christopher P Cannon; DR Wybenga; George A Fischer; C Grudzien; C Michael Gibson; James W Winkelman; Elliott M Antman; Eugene Braunwald
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.
American heart journal 1997;134(4):622-30.
1997: William H Maisel; Karen M Kuntz; SC Reimold; T H Lee; Elliott M Antman; Peter L Friedman; William G Stevenson
Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital.
Annals of internal medicine 1997;127(4):281-4.
1997: Elliott M Antman; C Grudzien; R N Mitchell; DB Sacks
Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T.
American heart journal 1997;133(5):596-8.
1997: Harry P Selker; Robert J Zalenski; Elliott M Antman; Tom P Aufderheide; Sheilah A Bernard; RO Bonow; W Brian Gibler; M D Hagen; P Johnson; J Lau; Robert A McNutt; Joseph P Ornato; J S Schwartz; J D Scott; P A Tunick; W D Weaver
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group.
Annals of emergency medicine 1997;29(1):13-87.
1997: Harry P Selker; Robert J Zalenski; Elliott M Antman; Tom P Aufderheide; Sheilah A Bernard; RO Bonow; W Brian Gibler; M D Hagen; P Johnson; J Lau; Robert A McNutt; Joseph P Ornato; J S Schwartz; J D Scott; P A Tunick; W D Weaver
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report.
Annals of emergency medicine 1997;29(1):1-12.
1996: Elliott M Antman; Milenko J Tanasijevic; B Thompson; M Schactman; Carolyn H McCabe; Christopher P Cannon; George A Fischer; A Y Fung; C Thompson; DR Wybenga; Eugene Braunwald
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.
The New England journal of medicine 1996;335(18):1342-9.
1996: C S Berkey; F Mosteller; J Lau; Elliott M Antman
Uncertainty of the time of first significance in random effects cumulative meta-analysis.
Controlled clinical trials 1996;17(5):357-71.
1996: Sally Greaves; J D Rutherford; Sary F Aranki; Lawrence H Cohn; Gregory S Couper; D H Adams; Robert J Rizzo; J J Collins; Elliott M Antman
Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery.
American heart journal 1996;132(3):572-8.
1996: Elliott M Antman
Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
Circulation 1996;94(5):911-21.
1996: Elliott M Antman
Maintaining sinus rhythm with antifibrillatory drugs in atrial fibrillation.
The American journal of cardiology 1996;78(4A):67-72.
1996: Elliott M Antman
Magnesium in acute myocardial infarction: overview of available evidence.
American heart journal 1996;132(2 Pt 2 Su):487-95; discussion 496-502.
1996: Arthur J Barsky; BA Delamater; S A Clancy; Elliott M Antman; David K Ahern
Somatized psychiatric disorder presenting as palpitations.
Archives of internal medicine 1996;156(10):1102-8.
1996: Thomas J McLaughlin; Stephen B Soumerai; DJ Willison; Jerry H Gurwitz; Catherine Borbas; Edward Guadagnoli; B McLaughlin; Nora Morris; S C Cheng; Paul J Hauptman; Elliott M Antman; L Casey; R Asinger; F Gobel
Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.
Archives of internal medicine 1996;156(7):799-805.
1995: Elliott M Antman
Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate control.
Journal of cardiovascular electrophysiology 1995;6(10 Pt 2):962-71.
1995: SC Reimold; Gervasio A Lamas; C O Cantillon; Elliott M Antman
Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables.
American heart journal 1995;129(6):1127-32.
1995: Elliott M Antman; C Grudzien; DB Sacks
Evaluation of a rapid bedside assay for detection of serum cardiac troponin T.
JAMA : the journal of the American Medical Association 1995;273(16):1279-82.
1995: Christopher P Cannon; Eugene Braunwald; Carolyn H McCabe; Elliott M Antman
The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade.
Journal of interventional cardiology 1995;8(2):117-35.
1994: John Z Ayanian; Paul J Hauptman; Edward Guadagnoli; Elliott M Antman; C L Pashos; Barbara J McNeil
Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction.
The New England journal of medicine 1994;331(17):1136-42.
1994: Elliott M Antman
Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.
Circulation 1994;90(4):1624-30.
1993: Scott D Solomon; Paul M Ridker; Elliott M Antman
Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis.
Circulation 1993;88(6):2575-81.
1993: SC Reimold; C O Cantillon; Peter L Friedman; Elliott M Antman
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
The American journal of cardiology 1993;71(7):558-63.
1993: S A Strickberger; R D Fish; Gervasio A Lamas; C Cantillon; S Bhatia; N McGowan; Elliott M Antman; Peter L Friedman
Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome.
The American journal of cardiology 1993;71(1):53-6.
1992: SC Reimold; T C Chalmers; J A Berlin; Elliott M Antman
Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality.
American heart journal 1992;124(4):924-32.
1992: Elliott M Antman; J A Berlin
Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine.
Circulation 1992;86(3):764-73.
1992: Elliott M Antman; J Lau; B Kupelnick; F Mosteller; T C Chalmers
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.
JAMA : the journal of the American Medical Association 1992;268(2):240-8.
1991: Thomas C Andrews; SC Reimold; J A Berlin; Elliott M Antman
Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials.
Circulation 1991;84(5 Suppl):III236-44.
1990: S E Coplen; Elliott M Antman; J A Berlin; P Hewitt; T C Chalmers
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
Circulation 1990;82(4):1106-16.
1990: Geoffrey H Tofler; Peter H Stone; Malcolm Maclure; E Edelman; V G Davis; T Robertson; Elliott M Antman; James E Muller
Analysis of possible triggers of acute myocardial infarction (the MILIS study).
The American journal of cardiology 1990;66(1):22-7.
1990: Elliott M Antman; T L Wenger; V P Butler; E Haber; T W Smith
Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
Circulation 1990;81(6):1744-52.
1990: P L Cole; A D Beamer; N McGowan; C O Cantillon; K Benfell; R A Kelly; L H Hartley; T W Smith; Elliott M Antman
Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent.
Circulation 1990;81(4):1260-70.
1990: Elliott M Antman; A D Beamer; C Cantillon; N McGowan; Peter L Friedman
Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.
Journal of the American College of Cardiology 1990;15(3):698-707.
1989: Joseph A Vita; Peter L Friedman; C Cantillon; Elliott M Antman
Efficacy of intravenous propafenone for the acute management of atrial fibrillation.
The American journal of cardiology 1989;63(17):1275-8.
1989: S Pohjola-Sintonen; James E Muller; Peter H Stone; Stefan N Willich; Elliott M Antman; V G Davis; Corette Parker; Eugene Braunwald
Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size.
American heart journal 1989;117(4):809-18.
1989: Elliott M Antman; T W Smith
Current concepts in the use of digitalis.
Advances in internal medicine 1989;34():425-54.
1988: A C Held; P L Cole; B Lipton; Joel M Gore; Elliott M Antman; J S Hockman; J Corrao; Robert J Goldberg; J S Alpert
Rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome.
American heart journal 1988;116(5 Pt 1):1330-6.
1988: Elliott M Antman; A D Beamer; C Cantillon; N McGowan; Lee Goldman; Peter L Friedman
Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter.
Journal of the American College of Cardiology 1988;12(4):1005-11.
1988: J M Kirshenbaum; R F Kloner; N McGowan; Elliott M Antman
Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
Journal of the American College of Cardiology 1988;12(3):773-80.
1988: B T Liang; Elliott M Antman; R Taus; JJ Collins; Frederick J Schoen
Atherosclerotic aneurysms of aortocoronary vein grafts.
The American journal of cardiology 1988;61(1):185-8.
1987: Elliott M Antman; J M Arnold; P L Friedman; T W Smith
Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1987;1(2):183-9.
1987: P L Ludmer; D S Baim; Elliott M Antman; D F Gauthier; M B Rocco; Peter L Friedman; Wilson S Colucci
Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
The American journal of cardiology 1987;59(15):1351-5.
1987: P L Ludmer; N E McGowan; Elliott M Antman; Peter L Friedman
Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Journal of the American College of Cardiology 1987;9(6):1357-63.
1986: Elliott M Antman; P L Ludmer; N McGowan; M Bosak; Peter L Friedman
Transtelephonic electrocardiographic transmission for management of cardiac arrhythmias.
The American journal of cardiology 1986;58(10):1021-4.